A citation-based method for searching scientific literature

Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
Times Cited: 143



Nadine Tung, Nancy U Lin, John Kidd, Brian A Allen, Nanda Singh, Richard J Wenstrup, Anne-Renee Hartman, Eric P Winer, Judy E Garber. J Clin Oncol 2016
Times Cited: 234




List of shared articles



Times cited

The Burden of Breast Cancer Predisposition Variants Across The Age Spectrum Among 10 000 Patients.
Yanin Chavarri-Guerra, Carolyn B Hendricks, Sandra Brown, Catherine Marcum, Mary Hander, Zdenka E Segota, Chris Hake, Sharon Sand, Thomas P Slavin, Arti Hurria,[...]. J Am Geriatr Soc 2019
5

Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
Jeffrey N Weitzel, Susan L Neuhausen, Aaron Adamson, Shu Tao, Charité Ricker, Asaf Maoz, Margalit Rosenblatt, Bita Nehoray, Sharon Sand, Linda Steele,[...]. Cancer 2019
14

Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer.
Karen A Cadoo, Diana L Mandelker, Semanti Mukherjee, Carolyn Stewart, Deborah DeLair, Vignesh Ravichandran, Preethi Srinivasan, Daire Hurley, Yelena Kemel, Angela G Arnold,[...]. JCO Precis Oncol 2019
1

Evaluation of Breast Cancer Patients with Genetic Risk in a University Hospital: Before and After the Implementation of a Heredofamilial Cancer Unit.
Miriam Lobo, Sara López-Tarruella, Soledad Luque, Santiago Lizarraga, Carmen Flores-Sánchez, Oscar Bueno, Jesús Solera, Yolanda Jerez, Ricardo González Del Val, María Isabel Palomero,[...]. J Genet Couns 2018
3

Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk.
Allison H West, Kathleen R Blazer, Jessica Stoll, Matthew Jones, Caroline M Weipert, Sarah M Nielsen, Sonia S Kupfer, Jeffrey N Weitzel, Olufunmilayo I Olopade. Fam Cancer 2018
10

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.
Thomas P Slavin, Kara N Maxwell, Jenna Lilyquist, Joseph Vijai, Susan L Neuhausen, Steven N Hart, Vignesh Ravichandran, Tinu Thomas, Ann Maria, Danylo Villano,[...]. NPJ Breast Cancer 2017
66

BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
Bárbara Alemar, Cleandra Gregório, Josef Herzog, Camila Matzenbacher Bittar, Cristina Brinckmann Oliveira Netto, Osvaldo Artigalas, Ida Vanessa D Schwartz, Jordy Coffa, Suzi Alves Camey, Jeffrey Weitzel,[...]. PLoS One 2017
20